Literature DB >> 20581459

Exposure to acute hypoxia induces a transient DNA damage response which includes Chk1 and TLK1.

Isabel M Pires1, Zuzana Bencokova, Chris McGurk, Ester M Hammond.   

Abstract

Severe hypoxia has been demonstrated to induce a replication arrest which is associated with decreased levels of nucleotides. Chk1 is rapidly phosphorylated in response to severe hypoxia and in turn deactivates TLK1 through phosphorylation. Loss of Chk1 has been shown to sensitize cells to hypoxia/reoxygenation. After short (acute) exposure to hypoxia this is due to an increased rate of reoxygenation-induced replication restart and subsequent p53-dependent apoptosis. After longer (chronic) exposure to hypoxia S phase cells do not undergo reoxygenation-induced replication restart. Cells exposed to these levels of hypoxia however are sensitive to loss of Chk1. This suggests a new role for Chk1 in the cell cycle response to reoxygenation.
© 2010 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581459      PMCID: PMC3040847          DOI: 10.4161/cc.9.13.12059

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  48 in total

Review 1.  Exploiting tumour hypoxia in cancer treatment.

Authors:  J Martin Brown; William R Wilson
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

Review 2.  Oxygen sensing and the DNA-damage response.

Authors:  Ester M Hammond; Muriel R Kaufmann; Amato J Giaccia
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

3.  Identification of human Asf1 chromatin assembly factors as substrates of Tousled-like kinases.

Authors:  H H Silljé; E A Nigg
Journal:  Curr Biol       Date:  2001-07-10       Impact factor: 10.834

4.  The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair.

Authors:  Claus Storgaard Sørensen; Lasse Tengbjerg Hansen; Jaroslaw Dziegielewski; Randi G Syljuåsen; Cecilia Lundin; Jiri Bartek; Thomas Helleday
Journal:  Nat Cell Biol       Date:  2005-01-23       Impact factor: 28.824

Review 5.  Biological consequences of tumor hypoxia.

Authors:  M Höckel; P Vaupel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

Review 6.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Authors:  J M Brown; A J Giaccia
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

7.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

8.  Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance.

Authors:  Norman Chan; Marianne Koritzinsky; Helen Zhao; Ranjit Bindra; Peter M Glazer; Simon Powell; Abdellah Belmaaza; Brad Wouters; Robert G Bristow
Journal:  Cancer Res       Date:  2008-01-15       Impact factor: 12.701

9.  Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.

Authors:  Darren R Krause; Jyoti C Jonnalagadda; Magtouf H Gatei; Herman H W Sillje; Bin-Bing Zhou; Erich A Nigg; Kumkum Khanna
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

Review 10.  Regulation of DNA repair in hypoxic cancer cells.

Authors:  Ranjit S Bindra; Meredith E Crosby; Peter M Glazer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

View more
  13 in total

Review 1.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

Review 2.  Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.

Authors:  Susan E Scanlon; Peter M Glazer
Journal:  DNA Repair (Amst)       Date:  2015-05-01

3.  Hypoxia-induced alterations of G2 checkpoint regulators.

Authors:  Grete Hasvold; Christin Lund-Andersen; Malin Lando; Sebastian Patzke; Sissel Hauge; ZhenHe Suo; Heidi Lyng; Randi G Syljuåsen
Journal:  Mol Oncol       Date:  2016-01-08       Impact factor: 6.603

4.  The effect of 1.5 T cardiac magnetic resonance on human circulating leucocytes.

Authors:  William R Critchley; Anna Reid; Julie Morris; Josephine H Naish; John P Stone; Alexandra L Ball; Triin Major; David Clark; Nick Waldron; Christien Fortune; Jakub Lagan; Gavin A Lewis; Mark Ainslie; Erik B Schelbert; Daniel M Davis; Matthias Schmitt; James E Fildes; Christopher A Miller
Journal:  Eur Heart J       Date:  2018-01-21       Impact factor: 29.983

5.  Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity.

Authors:  Samuel B Bader; Tiffany S Ma; Charlotte J Simpson; Jiachen Liang; Sakura Eri B Maezono; Monica M Olcina; Francesca M Buffa; Ester M Hammond
Journal:  Nucleic Acids Res       Date:  2021-07-21       Impact factor: 16.971

6.  Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis.

Authors:  Sarita Nehra; Varun Bhardwaj; Lilly Ganju; Deepika Saraswat
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

7.  Tumor hypoxia as a driving force in genetic instability.

Authors:  Kaisa R Luoto; Ramya Kumareswaran; Robert G Bristow
Journal:  Genome Integr       Date:  2013-10-24

8.  Combinations of Kinase Inhibitors Protecting Myoblasts against Hypoxia.

Authors:  Yunyi Kang; Matthew Tierney; Edison Ong; Linda Zhang; Carlo Piermarocchi; Alessandra Sacco; Giovanni Paternostro
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

9.  CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A.

Authors:  Cindy Cazares-Körner; Isabel M Pires; I Diane Swallow; Samuel C Grayer; Liam J O'Connor; Monica M Olcina; Martin Christlieb; Stuart J Conway; Ester M Hammond
Journal:  ACS Chem Biol       Date:  2013-05-10       Impact factor: 5.100

Review 10.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Richard A Franklin; Giuseppe Montalto; Melchiorre Cervello; Massimo Libra; Saverio Candido; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Ferdinando Nicoletti; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Francesca Chiarini; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.